PDI Inc (NASDAQ:PDII)

PDI, Inc. provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States. It also provides other promotional services including clinical educator services, digital communications, teledetailing and with the formation of its new business unit, Interpace BioPharma, the company provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. The company operates its business through three segment: Sales Services, Marketing Services and Product Commercialization Services. The Sales Services segment focuses primarily on product detailing, includes its outsourced sales teams and a new business unit, EngageCE. The Marketing Services segment includes two business units: Group DCA and PDI Voice. The Group DCA unit focuses on the creation, design and implementation of interactive digital communications, including its award-winning e-detailing programs to the healthcare community on behalf of its pharmaceutical, biotechnology and healthcare customers. The PDI Voice unit focuses on the creation of teledetailing programs that are executed via its tele-representatives. The Product Commercialization Services segment provides sales and marketing support services through Interpace BioPharma unit. The Interpace BioPharma unit provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. PDI was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.